Found: 14
Select item for more details and to access through your institution.
Clinical Routine FDG-PET Imaging of Suspected Progressive Supranuclear Palsy and Corticobasal Degeneration: A Gatekeeper for Subsequent Tau-PET Imaging?
- Published in:
- Frontiers in Neurology, 2018, p. N.PAG, doi. 10.3389/fneur.2018.00483
- By:
- Publication type:
- Article
Dual-Phase β-Amyloid PET Captures Neuronal Injury and Amyloidosis in Corticobasal Syndrome.
- Published in:
- Frontiers in Aging Neuroscience, 2021, v. 13, p. N.PAG, doi. 10.3389/fnagi.2021.661284
- By:
- Publication type:
- Article
<sup>18</sup>F‐PI‐2620 tau‐PET in corticobasal syndrome (ActiGliA cohort): Neuroimaging: Other neurodegenerative disorders.
- Published in:
- Alzheimer's & Dementia: The Journal of the Alzheimer's Association, 2020, v. 16, n. 11, p. 1, doi. 10.1002/alz.041469
- By:
- Publication type:
- Article
24 Individual Differences in CAMCOG-DS Performance in Children and Adults with Down's Syndrome and Relationship to Language and Reasoning.
- Published in:
- 2023
- By:
- Publication type:
- Abstract
Impact of Partial Volume Correction on [ 18 F]GE-180 PET Quantification in Subcortical Brain Regions of Patients with Corticobasal Syndrome.
- Published in:
- 2022
- By:
- Publication type:
- Correction Notice
Atrophy in the Thalamus But Not Cerebellum Is Specific for C9orf72 FTD and ALS Patients - An Atlas-Based Volumetric MRI Study.
- Published in:
- Frontiers in Aging Neuroscience, 2018, p. 1, doi. 10.3389/fnagi.2018.00045
- By:
- Publication type:
- Article
Serum Beta‐Synuclein Is Higher in Down Syndrome and Precedes Rise of pTau181.
- Published in:
- Annals of Neurology, 2022, v. 92, n. 1, p. 6, doi. 10.1002/ana.26360
- By:
- Publication type:
- Article
Detection Gap of Right-Asymmetric Neuronal Degeneration by CERAD Test Battery in Alzheimer's Disease.
- Published in:
- Frontiers in Aging Neuroscience, 2021, p. N.PAG, doi. 10.3389/fnagi.2021.611595
- By:
- Publication type:
- Article
In Vivo Assessment of Neuroinflammation in 4‐Repeat Tauopathies.
- Published in:
- Movement Disorders, 2021, v. 36, n. 4, p. 883, doi. 10.1002/mds.28395
- By:
- Publication type:
- Article
Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Metabolic Correlates of Dopaminergic Loss in Dementia with Lewy Bodies.
- Published in:
- Movement Disorders, 2020, v. 35, n. 4, p. 595, doi. 10.1002/mds.27945
- By:
- Publication type:
- Article
The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset.
- Published in:
- 2014
- By:
- Publication type:
- Letter
Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson's disease.
- Published in:
- Acta Neuropathologica, 2013, v. 125, n. 6, p. 795, doi. 10.1007/s00401-013-1114-9
- By:
- Publication type:
- Article
Additive value of amyloid-PET in routine cases of clinical dementia work-up after FDG-PET.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 13, p. 2239, doi. 10.1007/s00259-017-3832-z
- By:
- Publication type:
- Article